About
Seems to be Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalBiotech
Team (19)
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
1,948
By Phase
PHASE2/PHASE3: 1PHASE3: 1PHASE2: 1
By Status
NOT_YET_RECRUITING: 1RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT07210723Lead Sponsor
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
PHASE2/PHASE3Not yet recruiting
332 participants
Started: Nov 30, 2025 · Completed: Jan 31, 2028
NCT07001800Lead Sponsor
A Study to Investigate Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis
PHASE3Recruiting
1,410 participants
Started: Jun 27, 2025 · Completed: Sep 30, 2030
NCT06864104Lead Sponsor
A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)
PHASE2Active, not recruiting
206 participants
Started: Apr 10, 2025 · Completed: Mar 6, 2026
Locations (1)
Headquarters
South SF, CA, United States
Map
Loading map...